Cargando…
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
OBJECTIVES: Evidence supports tocilizumab (TCZ) benefit and safety in adult patients with severe COVID-19. However, its effectiveness in critically ill older adult patients remains questionable. Thus, the study aimed to evaluate the safety and effectiveness of TCZ in older critically ill patients wi...
Autores principales: | Korayem, Ghazwa B., Aljuhani, Ohoud, Altebainawi, Ali F., Shaya, Abdulrahman I. Al, Alnajjar, Lina I., Alissa, Abdulrahman, Aldhaeefi, Mohammed, Kensara, Raed, Al Muqati, Hessa, Alhuwahmel, Abdulmohsen, Alhuthaili, Omar, Vishwakarma, Ramesh, Aldardeer, Namareq, Eljaaly, Khalid, Alharbi, Aisha, Harbi, Shmeylan Al, Katheri, Abdulmalik Al, Bekairy, Abdulkareem M. Al, Aljedai, Ahmed, Al Sulaiman, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121644/ https://www.ncbi.nlm.nih.gov/pubmed/35605948 http://dx.doi.org/10.1016/j.ijid.2022.05.038 |
Ejemplares similares
-
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022) -
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021) -
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
por: Aljuhani, Ohoud, et al.
Publicado: (2021) -
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021) -
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)